Search Articles
SAN FRANCISCO – Rigel Pharmaceutical shareholders cannot pursue fraud claims over marketing of the rheumatoid arthritis drug R788, the 9th Circuit ruled Thursday.
Categories /
Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.